NCT01385228 - Pazopanib, Docetaxel, Prednisone Prostate | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

July 31, 2015

Study Completion Date

February 29, 2016

Conditions

Prostate Cancer

Interventions

DRUG

Pazopanib

"Dose Level Xa - daily administration of pazopanib on days 1 through 21 starting at 400mg with a maximum dose of 1000mg."

DRUG

Docetaxel

Docetaxel given IV on Day 1 starting dose 60mg/m2 increase to 75mg/m2

DRUG

Pazopanib

"Dose Level Xb - daily administration of pazopanib on days 3 through 19 starting at 400mg with a maximum dose of 1000mg."

DRUG

Prednisone

5mg Prednisone given twice daily days 1-21.

DRUG

Pegfilgrastim

Trial Locations (2)

Duke Cancer Institute, Durham

The University of Chicago, Chicago